Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Features include always present findings: Ataxia, Global developmental delay, and Decreased activity of mitochondrial complex I; and common findings: Bilateral tonic-clonic seizure, Generalized myoclonic seizure, Shrinkage of the cerebellum (cerebellar atrophy), and Seizure and others.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Brain and nerves | 13 | Bilateral tonic-clonic seizure, Generalized myoclonic seizure, Seizure |
NDUFA1 encodes NADH:ubiquinone oxidoreductase subunit A1 (70 aa). Accessory subunit of the mitochondrial membrane respiratory chain NADH dehydrogenase (Complex I), that is believed not to be involved in catalysis. Highest expression in Heart Left Ventricle (754.6 TPM) and Heart Atrial Appendage (614.2 TPM).
Mitochondrial complex I deficiency, nuclear type 12 is associated with mutations in the NDUFA1 gene on chromosome X.
NDUFA1 is classified as a druggable target (Enzyme category) with score 0.3.
Genetic testing for NDUFA1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 3 always present features, 23 common features.
No clinical trials have been registered for mitochondrial complex I deficiency, nuclear type 12.
5 publications have been identified in PubMed for mitochondrial complex I deficiency, nuclear type 12. Research spans Basic Science / Preclinical (60%), Other (20%), and Review / Meta-Analysis (20%).
Kaiyrzhanov R (2025). [PMID: 39963288](https://pubmed.ncbi.nlm.nih.gov/39963288/). *Brain Commun*. [Other]
Chai G (2025). [PMID: 40624018](https://pubmed.ncbi.nlm.nih.gov/40624018/). *Cell Death Dis*. [Basic Science / Preclinical]
Mao G (2025). [PMID: 40885831](https://pubmed.ncbi.nlm.nih.gov/40885831/). *Sci Rep*. [Basic Science / Preclinical]
Gupta P (2025). [PMID: 40016208](https://pubmed.ncbi.nlm.nih.gov/40016208/). *Nat Commun*. [Basic Science / Preclinical]
Zhang X (2024). [PMID: 39850733](https://pubmed.ncbi.nlm.nih.gov/39850733/). *Front Neurol*. [Review / Meta-Analysis]
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 6:54 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Muscles | 6 | Shrinkage of the cerebellum (cerebellar atrophy), Low muscle tone (hypotonia), Generalized hypotonia |
Lab test results | 2 | Increased circulating lactate concentration, Decreased activity of mitochondrial complex I |
Eyes | 1 | Nystagmus |
Ears | 1 | Progressive sensorineural hearing impairment |